Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan · Delayed Price · Currency is TWD 27.85
+0.50 (1.83%)
At close: Jul 9, 2026
Genovate Biotechnology Market Cap
Genovate Biotechnology has a market cap or net worth of 3.81 billion as of July 9, 2026. Its market cap has increased by 59.96% in one year.
Market Cap
3.81B
Enterprise Value
2.70B
Revenue
471.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.85
Market Cap Chart
Since November 3, 2008, Genovate Biotechnology's market cap has increased from 664.80M to 3.81B, an increase of 472.88%. That is a compound annual growth rate of 10.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.81B | 20.87% |
| Dec 31, 2025 | 3.15B | 35.56% |
| Dec 31, 2024 | 2.32B | -20.11% |
| Dec 29, 2023 | 2.91B | -17.02% |
| Dec 30, 2022 | 3.51B | 31.05% |
| Dec 30, 2021 | 2.68B | -15.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senhwa Biosciences | 4.01B |
| OBI Pharma | 3.89B |
| Formosa Pharmaceuticals | 3.67B |
| Sagittarius Life Science | 3.52B |
| SYN-TECH Chem. & Pharm. | 3.34B |
| BioGend Therapeutics | 3.23B |
| Shine-On BioMedical | 3.23B |
| Energenesis Biomedical CO.,LTD. | 3.17B |